http://galectintherapeutics.com
Galectin Therapeutics, Inc. Company Intro
Galectin Therapeutics looks to help patients with NASH cirrhosis and cancer. Galectin’s lead drug (GR-MD-02, or belapectin) is a galectin-3 inhibitor.
Industry
Healthcare
Galectin Therapeutics, Inc. Headquaters
4960 Peachtree Industrial Boulevard
Norcross,30071
United States
Galectin Therapeutics, Inc. Share price
14 Sep 2022 09:18 GMT
$1.8000
-0.03 (-1.64 %)
Galectin Therapeutics, Inc. Market cap
$109.188 M
WMC RANKING
2023
Galectin Therapeutics, Inc. # 397
BiotechnologyLatest Galectin Therapeutics, Inc. News
30 Mar 2023
North American Morning Briefing: Stocks Seen -2-
Edgio Inc (EGIO) is expected to report for Full year. Empire Petroleum Corp (EP) is expected to report for 4Q. Galectin Therapeutics (GALT) is expected to...
30 Mar 2023
GALECTIN THERAPEUTICS INC Management's Discussion ...
GALECTIN THERAPEUTICS INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) · General and administrative expenses...
30 Mar 2023
Galectin Therapeutics Reports
Galectin Therapeutics Reports 2022 Financial Results and Provides Business ... Inc. ( GALT), the leading developer of therapeutics that target galectin...
WMC Market Score
WMC Market to Revenue Score
Galectin Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Galectin Therapeutics, Inc. | USD | $0 | $26,177 | $-26,392 | $1,092M | 397 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Galectin Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Galectin Therapeutics, Inc. Post vs Top 4 Industry Competitors
Galectin Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Galectin Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Galectin Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Galectin Therapeutics, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 100 | 100 | 0 | 0 | 0 | 100 |
| Incyte Corporation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
